Fator VIII Recombinante de 3ª Geração (octocog alfa 250 e 500UI pó sol inj.)

ID 6583792 · Portal BASE
Price
Base Price
€0 .00
Effective Price
€86,462 .00
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33600000
Location
Portugal
Bidder Count
—
Winner
SHIRE PHARMACEUTICALS PORTUGAL, LDA
NIF 509264662
Company
Dates
Publication
20 May 2020
Celebration
19 Aug 2019
Contracting Entity
Centro Hospitalar Universitário Lisboa Central, EPE
NIF 508080142
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 40 · MEDIUM RISK
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
HIGH
Publication Date
20 May 2020
Signing Date
19 Aug 2019
Days Late
275
Rule
A2/A3 late publication: 275 days after signing (threshold: 10)
Detected 2026-03-06